Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
沙夫西尼布酯治疗未经化疗和放疗的异柠檬酸脱氢酶 1 突变 WHO 2 级胶质瘤患者的 II 期研究
期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noaf258
Arakawa, Yoshiki; Saito, Ryuta; Kanemura, Yonehiro; Mishima, Kazuhiko; Koriyama, Shunichi; Narita, Yoshitaka; Kumabe, Toshihiro; Motomura, Kazuya; Sugiyama, Kazuhiko; Yamasaki, Fumiyuki; Mukasa, Akitake; Kanamori, Masayuki; Kuga, Daisuke; Nagane, Motoo; Kakurai, Yasuyuki; Isobe, Koji; Nakamura, Hideo